Top Markets
Coin of the day
Medeon Biodesign, Inc. Medeon Biodesign, Inc.

Medeon Biodesign, Inc.

6499
Clasificación en acciones #17676
Medeon Biodesign, Inc. engages in the research and development, manufacturing,... Medeon Biodesign, Inc. engages in the research and development, manufacturing, and sale of medical devices in the United States. The company focuses on developing devices for minimally invasive surgeries, such as Cross-Seal, a large bore vascular closure system; Urocross, an expander system for treating lower urinary tract symptoms associated with benign prostatic hyperplasia; Duett, a vascular graft system; PUMA, solution to treat orthopedic extremity injuries; ClickClean, a solution to view throughout laparoscopic surgeries; and AbClose to prevent port site herniation caused by improper closure. It is engaged in the medical device contract manufacturing; and manufacture and sale of injection molding and components of medical devices. Medeon Biodesign, Inc. was incorporated in 2012 and is based in Taipei, Taiwan.
Precio por acción
$2.38
Capitalización bursátil
$231.21M
Cambio (1 día)
0.94%
Cambio (1 año)
-25.60%
País
TW
Comercio Medeon Biodesign, Inc. (6499)

Categoría

Historial de rendimiento por dividendo de Medeon Biodesign, Inc. (6499)
Rendimiento por dividendo (TTM) de Medeon Biodesign, Inc. (símbolo bursátil: 6499) al 2026: 0
Rendimiento promedio por dividendo de los últimos 5 años: 0.00%
Historial de rendimiento por dividendo de Medeon Biodesign, Inc. (6499) desde 2026 hasta 2026
Rendimiento por dividendo al final de cada año (TTM)
Año Rendimiento por dividendo Cambiar
Not enough data for the provided dates.
Rendimientos por dividendo (TTM) de empresas similares o competidoras